Total Visits

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial1

File Visits

Downloads

Select a period of time:

Number of downloads in the range

Downloads

Views

Views
February 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
Uruguay1
 

Top cities views

Views
Montevideo1